IM Cannabis Corp. (IMCC)
After hours:
| Previous close | 0.5834 |
| Open | 0.5689 |
| Bid | 0.5563 x 600 |
| Ask | 0.6298 x 300 |
| Day's range | 0.5600 - 0.6499 |
| 52-week range | 0.1890 - 1.4300 |
| Volume | |
| Avg. volume | 677,060 |
| Market cap | 8.17M |
| Beta (5Y monthly) | 1.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5400 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireIMC to transfer its Oranim Pharmacy shares back to the seller
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
- PR Newswire
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, entered, through its subsidiary, a strategic distribution agreement with Vessel Brand Inc, a subsidiary of Flora Growth Corp. ("Flora"), a global consumer-packaged goods leader and pharmaceutical distributor, headquartered in Carlsbad, CA.
- PR Newswire
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive
